The Conversation (0)
Life Science Big News Roundup: Chemesis International Inc. & Rapid Dose Therapeutics Sign a Definitive Agreement; Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology; BriaCell Initiates Dosing in Phase I/IIa Combination Study with KEYTRUDA® or YERVOY®
Oct. 12, 2018 10:32AM PST
Life Science Investing News
In case you missed it, here is this week’s life science big news roundup.
In case you missed it, here is this week’s life science big news roundup:
Biotech:
- Chemesis International Inc. & Rapid Dose Therapeutics Sign a Definitive Agreement for QuickStrip™ Oral Thin Strips
- Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus
- BriaCell Initiates Dosing in Phase I/IIa Combination Study with KEYTRUDA® or YERVOY®
- NanoSphere Health Sciences and Vertical Companies™ Commence Production in California
- MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement
To see our previous Life Science Investing Big News Roundups, please click here.